Go Deep
Endovia Health Sciences, Inc.
Endovia Health Sciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -16,542 | -0.0 | -0.10 | -0.44 | 13.92 |
| Oct 2026 | -16,542 | -0.0 | -0.10 | -0.44 | 13.83 |
| Oct 2026 | -19,334 | -0.0 | -0.10 | -0.44 | 12.80 |
| Oct 2026 | -19,341 | -0.0 | -0.10 | -0.44 | 13.75 |
| Oct 2026 | -19,347 | -0.0 | -0.11 | -0.44 | 14.47 |
| Oct 2026 | -19,361 | -0.0 | -0.10 | -0.44 | 14.09 |
Endovia Health Sciences, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 4,224.0 | -365,206.0 | 0.0 |
| Net Profit | -2,054,787.0 | -2,136,469.0 | -3,205,257.0 | -9,886,045.0 |
| EPS | -0.8 | -1.9 | — | -18.0 |
Endovia Health Sciences, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 73,066.0 | 801,273.0 | 18,850,152.0 | 18,087,486.0 | — |
| Net Profit | -25,234,834.0 | -23,756,551.0 | -21,003,757.0 | -21,690,469.0 | — |
| EPS | -47.9 | -70.7 | -79.2 | -92.8 | — |
Endovia Health Sciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 965,694.0 | 2,759,185.0 | 9,898,768.0 | 17,304,703.0 | — |
| Total Liabilities | 16,266,522.0 | 21,394,034.0 | 15,504,094.0 | 7,982,569.0 | — |
| Total Equity | -15,300,828.0 | -18,634,849.0 | -5,605,326.0 | 9,322,134.0 | — |
Owes vs Owns
Endovia Health Sciences, Inc. owed $15.6 for every $1 it owned in Jun 2026, up from $0.46 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 15.6× | 16.8× | 7.75× | 1.57× | 0.46× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Endovia Health Sciences, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 29.1%Receivables 11.3%Inventory 3.5%Fixed assets (tangible) 6.3%Long-term investments 25.9%Other assets 23.9%
How it's funded — Dec 2025
Short-term debt 40.7%Payables 29.6%Other liabilities 29.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 0.3 | 0.0 | 0.4 | 4.4 |
| Receivables | 0.1 | 0.4 | 1.1 | 2.2 |
| Inventory | 0.0 | 0.3 | 2.3 | 3.7 |
| Fixed assets (tangible) | 0.1 | 0.4 | 0.9 | 1.2 |
| Intangible assets | 0.0 | 0.0 | 4.7 | 5.1 |
| Long-term investments | 0.2 | 0.2 | 0.2 | 0.2 |
| Other assets | 0.2 | 1.4 | 0.3 | 0.4 |
| Liabilities & equity | ||||
| Short-term debt | 6.6 | 10.2 | 8.3 | 1.1 |
| Long-term debt | 0.0 | 2.0 | 0.5 | 2.5 |
| Payables | 4.8 | 3.6 | 4.4 | 3.4 |
| Other liabilities | 4.8 | 5.6 | 2.3 | 1.0 |
| Shareholders' equity | -15.3 | -18.6 | -5.6 | 9.3 |
| Net tangible assets | -15.3 | -18.6 | -10.3 | 4.2 |
Endovia Health Sciences, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -4,789,139.0 | -7,795,900.0 | -10,189,263.0 | -14,073,419.0 | — |
| Investing Activities | 0.0 | 0.0 | -14,113.0 | -102,698.0 | — |
| Financing Activities | 5,104,137.0 | 7,544,759.0 | 6,147,720.0 | 14,446,951.0 | — |